Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Drug for an 'undruggable' protein

Scientists have long aimed to develop drugs against the cancer-associated protein KRAS, but without success. An approach that targets the oncoprotein's cellular localization reignites lost enthusiasm. See Letter p.638

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


  1. *This article and the paper under discussion2 were published online on 22 May 2013.


  1. Cox, A. D. & Der, C. J. Small GTPases 1, 2–27 (2010).

    Article  Google Scholar 

  2. Zimmermann, G. et al. Nature 497, 638–642 (2013).

    Article  ADS  CAS  Google Scholar 

  3. Berndt, N., Hamilton, A. D. & Sebti, S. M. Nature Rev. Cancer 11, 775–791 (2011).

    Article  CAS  Google Scholar 

  4. Ahearn, I. M., Haigis, K., Bar-Sagi, D. & Philips, M. R. Nature Rev. Mol. Cell Biol. 13, 39–51 (2012).

    Article  CAS  Google Scholar 

  5. Philips, M. R. Nature Cell Biol. 14, 128–129 (2012).

    Article  CAS  Google Scholar 

  6. Nancy, V., Callebaut, I., El Marjou, A. & de Gunzburg, J. J. Biol. Chem. 277, 15076–15084 (2002).

    Article  CAS  Google Scholar 

  7. Ismail, S. A. et al. Nature Chem. Biol. 7, 942–949 (2011).

    Article  CAS  Google Scholar 

  8. Chandra, A. et al. Nature Cell Biol. 14, 148–158 (2012).

    Article  CAS  Google Scholar 

  9. Zhang, H. et al. Proc. Natl Acad. Sci. USA 104, 8857–8862 (2007).

    Article  ADS  CAS  Google Scholar 

  10. Laheru, D. et al. Invest. New Drugs 30, 2391–2399 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Channing J. Der.

Ethics declarations

Competing interests

C.J.D. has received honoraria from Bristol-Myers Squibb, Eli Lilly and Merck, and has a research contract with GlaxoSmithKline.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baker, N., Der, C. Drug for an 'undruggable' protein. Nature 497, 577–578 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer